- May 14, 2018Treatment for MRSA no longer more costly than for susceptible Staph aureus infections
Infections caused by one of the most common drug resistant bacteria in the US, methicillin-resistant Staphylococcus aureus, are no more expensive to treat than the methicillin-susceptible version of the same bacteria.
Read moreRead more Read More - May 10, 2018The catch-22 of mass-prescribing antibiotics.
Wired– May 10, 2018. “I am not saying this kind of use has no place at all; it may have a role for some populations and for some period of time,” says Ramanan Laxminarayan, the founder of the Center for Disease Dynamics, Economics and Policy and a prominent researcher into developing-world antibiotic policy. “But we have […]
Read moreRead more Read More - May 3, 2018Antibiotic-resistant Acinetobacter baumannii infections in children across the US: After 2008, a downward trend reported.
Outbreak News Today– May 3, 2018. “In the first national study of the prevalence of antibiotic-resistant Acinetobacter baumannii infections in children across the US,researchers from Center for Disease Dynamics, Economics, & Policy (CDDEP) in Washington, DC and Rush University in Chicago, IL examined national and regional trends of antibiotic resistance in clinical specimens over a 13-year period.”
Read moreRead more Read More - May 2, 2018Mixed progress on drug resistance in A. baumannii infections in children
An overall increase from 1999 is balanced by modest improvement since 2008.
Read moreRead more Read More - April 27, 2018Fresh food samples found to be resistant to antibiotics: new study reveals.
Hungry Forever– April 27, 2018. “After studies conducted by Indian researchers from the Centre for Disease Dynamics, Economics & Policy (CDDEP) found a high level of antibiotic-resistant pathogens in chicken, it has recently been found that fresh food samples contain bacteria that is resistant to even the most powerful antibiotic.”
Read moreRead more Read More - April 25, 2018Giving at-risk children pre-emptive antibiotics reduces deaths.
International Journal of Science– April 25, 2018. ‘This antibiotics strategy comes at a cost, says Ramanan Laxminarayan, director of the Center for Disease Dynamics, Economics and Policy in Washington DC. If resistance develops against azithromycin, diseases treated by the drug, including gonorrhea, would become harder to combat.’
Read moreRead more Read More - April 20, 2018Antibiotic resistance is becoming a massive problem.
Longevity Live– April 20, 2018. “The study, which analyzed human antibiotic consumption in 76 countries, is the most comprehensive assessment of global trends to date. Researchers from the Center for Disease Dynamics, Economics & Policy (CDDEP), Princeton University, ETH Zurich and the University of Antwerp conducted the study, which found that antibiotic consumption rates increased […]
Read moreRead more Read More - April 8, 2018Antibiotics use in India has risen by 65% in the last 15 years.
Free Press Journal- April 8, 2018. “Worryingly, use of third-generation antibiotics such as cephalosporins and linezolid’s used to treat multidrug-resistant bacteria have increased dramatically in India since 2000, reports the study, done by CDDEP, Princeton University, ETH Zurich and the University of Antwerp.”
Read moreRead more Read More - March 26, 2018Global antibiotic use rises, fueled by economic growth.
Center for Infectious Disease Research and Policy– March 26, 2018. “If things continue at the same rate they’re going, without any sort of deviation, things are just going to get worse,” study co-author Eili Klein, PhD, a professor in the department of emergency medicine at Johns Hopkins University and fellow at the Center for Disease […]
Read moreRead more Read More
News
One Health Trust’s work and researchers are featured in international media outlets. Find resources to help understand OHT’s work.